Project Details
Description
Primary Immune Deficiency Treatment Consortium (PIDTC): A resource to drive scientific and clinical advances related to the treatment of inborn errors of immunity
| Status | Active |
|---|---|
| Effective start/end date | 3/1/25 → 8/31/29 |
Funding
- UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
- NATIONAL INSTITUTES OF HEALTH (NIH)
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.